CRDF/ 01/27/2026 · 11:02 AM Cardiff Oncology Drops 34% After CEO and CFO Resign Cardiff Oncology shares fall sharply as CEO and CFO step down amid leadership transition; interim CEO appointed to guide next phase of drug development.
